Spatial multi-omic map of human myocardial infarction.
Kuppe C, Ramirez Flores RO, Li Z, Hayat S, Levinson RT, Liao X, Hannani MT, Tanevski J, Wünnemann F, Nagai JS, Halder M, Schumacher D, Menzel S, Schäfer G, Hoeft K, Cheng M, Ziegler S, Zhang X, Peisker F, Kaesler N, Saritas T, Xu Y, Kassner A, Gummert J, Morshuis M, Amrute J, Veltrop RJA, Boor P, Klingel K, Van Laake LW, Vink A, Hoogenboezem RM, Bindels EMJ, Schurgers L, Sattler S, Schapiro D, Schneider RK, Lavine K, Milting H, Costa IG, Saez-Rodriguez J, Kramann R.
Nature. 2022 Aug;608(7924):766-777. doi: 10.1038/s41586-022-05060-x. Epub 2022 Aug 10.
Connexin43 overexpression promoted ferroptosis and increased myocardial vulnerability to ischemia-reperfusion injury in type 1 diabetic mice.
Yang Y, Chen J, Zhou J, Zhou D, Zhang A, Jiang Y, Lin J, Xia W, Cai Y, Han R, Lu Y, Liu D, Xia Z.
Int J Med Sci. 2024 Sep 9;21(12):2365-2378. doi: 10.7150/ijms.95170. eCollection 2024.
CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus.
Chen C, Lin LY, Chen JW, Chang TT.
Cardiovasc Diabetol. 2023 Jul 7;22(1):172. doi: 10.1186/s12933-023-01900-w.
Calciphylaxis, beware the ophthalmic mimic: A case series.
Guymer C, Jahan S, Bahrami B, Sia D, Tan BQ, McDonald S, Simon S.
Clin Nephrol Case Stud. 2023 Dec 12;11:136-146. doi: 10.5414/CNCS111088. eCollection 2023.
Transcriptome wide changes in long noncoding RNAs in diabetic ischemic heart disease.
Rai AK, Muthukumaran NS, Nisini N, Lee T, Kyriazis ID, de Lucia C, Piedepalumbo M, Roy R, Uchida S, Drosatos K, Bisserier M, Katare R, Goukassian D, Kishore R, Garikipati VNS.
Cardiovasc Diabetol. 2024 Oct 17;23(1):365. doi: 10.1186/s12933-024-02441-6.
Diabetic muscle infarction of the forearm in a patient with long-standing type 1 diabetes.
Cardillo S, Huse JT, Iqbal N.
Endocr Pract. 2006 Mar-Apr;12(2):188-92. doi: 10.4158/EP.12.2.188.
N-acetylcysteine Protects Against Myocardial Ischemia-Reperfusion Injury Through Anti-ferroptosis in Type 1 Diabetic Mice.
Zhou D, Yang Y, Chen J, Zhou J, He J, Liu D, Zhang A, Yuan B, Jiang Y, Xia W, Han R, Xia Z.
Cardiovasc Toxicol. 2024 May;24(5):481-498. doi: 10.1007/s12012-024-09852-7. Epub 2024 Apr 22.
Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes.
Baumgardt SL, Fang J, Fu X, Liu Y, Xia Z, Zhao M, Chen L, Mishra R, Gunasekaran M, Saha P, Forbess JM, Bosnjak ZJ, Camara AKS, Kersten JR, Thorp EB, Kaushal S, Ge ZD.
Cardiovasc Res. 2024 Oct 14;120(12):1456-1471. doi: 10.1093/cvr/cvae144.
Diabetic muscle infarction.
Umpierrez GE, Stiles RG, Kleinbart J, Krendel DA, Watts NB.
Am J Med. 1996 Sep;101(3):245-50. doi: 10.1016/S0002-9343(96)00156-8.
Diabetic muscle infarction in end-stage renal disease: A scoping review on epidemiology, diagnosis and treatment.
Yong TY, Khow KSF.
World J Nephrol. 2018 Mar 6;7(2):58-64. doi: 10.5527/wjn.v7.i2.58.
